Abstract Details
|
Tomoko Takeda, MD
(University of Fukui)
PRESENTER |
No disclosure on file |
| Masamichi Ikawa (University of Fukui) | No disclosure on file |
| No disclosure on file | |
| No disclosure on file | |
| No disclosure on file | |
| No disclosure on file | |
| No disclosure on file | |
| Shigeo Murayama, MD, PhD (Brain Bank for Aging Research (Neuropathology), TMIGG) | No disclosure on file |
| No disclosure on file | |
| Hidehiko Okazawa, MD, PhD (Hidehiko Okazawa) | No disclosure on file |
| Makoto Yoneda (Univ of Fukui) | No disclosure on file |
| Diego Cadavid, MD, FAAN (Verge Genomics) | Dr. Cadavid has received personal compensation for serving as an employee of Verge Genomics. Dr. Cadavid has received personal compensation for serving as an employee of Vertex Pharmaceuticals. Dr. Cadavid has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novo Nordisk. Dr. Cadavid has or had stock in Verge Genomics.Dr. Cadavid has or had stock in Vertex Pharmaceuticals. |